7 Papers
1 Citations
Ruma Baksi is an academic researcher from Nirma University of Science and Technology. The author has contributed to research in topics: Cancer & Chemistry. The author has an hindex of 4, co-authored 7 publications.
Chat about Author
Papers
In vitro and in vivo anticancer efficacy potential of Quercetin loaded polymeric nanoparticles.
TL;DR: The aim of the present study was to develop quercetin loaded chitosan nanoparticles (QCT-CS NPs) with enhanced encapsulation efficiency and sustained release property and exhibited enhanced efficacy of QCT- CS NPs in cancer therapy.
146
Targeting receptors of advanced glycation end products (RAGE): Preventing diabetes induced cancer and diabetic complications.
TL;DR: Inhibition of RAGE signaling can prevent diabetic complications and cancer in diabetic patients and can be helpful in the management of worsening diabetic complications in diabetic cancer patients.
32
Phytochemical analysis and pharmacological evaluation of methanolic leaf extract of Moringa oleifera Lam. in ovalbumin induced allergic asthma
Sandhya Suresh,Abu Sufiyan Chhipa,Mansi Gupta,Sunali Lalotra,S.S. Sisodia,Ruma Baksi,Manish Nivsarkar +6 more
TL;DR: In this article, the anti-asthmatic effects of Moringa oleifera leaf extract (MOLE) on ovalbumin-induced asthma in guinea pigs were evaluated.
27
Anti-leukemic and anti-angiogenic effects of d-Limonene on K562-implanted C57BL/6 mice and the chick chorioallantoic membrane model
Bhavini B. Shah,Ruma Baksi,Kiranj K. Chaudagar,Manish Nivsarkar,Anita A. Mehta +4 more
- 21 Nov 2018
TL;DR: In this study, the in vivo effect of d‐Limonene on a K562‐induced model of chronic myeloid leukemia (CML) in C57BL/6 mice is evaluated.
20
Anticancer studies on methanolic extract of aerial parts of Uraria Picta (Jacq.) DC
TL;DR: The methanolic extract of aerial parts of Uraria picta (Jacq) is effective in inhibiting tumor growth and has significant anticancer property as discussed by the authors, and significant reduction in tumor volume was observed in mice receiving cisplatin and MEUP at both dose levels.
5